• Advising on some of the largest merger control cases over the past decade, focusing heavily on regulated sectors such as life sciences (e.g. pricing and reimbursement issues for ultra rare diseases).
  • Developing a Trade and Brexit advisory group, representing e.g. the most affected EU Members States' fishing fleets.
  • Advising content driven companies on their regulatory challenges with a particular focus on antitrust aspects of data, privacy and intellectual property.